[1]
Raharjo, S.J. et al. 2026. Stevia-Derived Diterpenoids as Potential Dopamine D2 Receptor Antagonists for Insomnia and Schizophrenia Therapy: An In Silico Study. Iraqi Journal of Pharmaceutical Sciences . 35, 2 (Jun. 2026), 105–124. DOI:https://doi.org/10.31351/vol35iss2pp105-124.